Stay updated on Nivolumab Safety in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Safety in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Safety in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. This is a minor technical update that does not affect study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-03-11T18:09:07.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed prior notices, including the government-funding status notice and Revision: v3.4.1; these are administrative updates to the website's metadata rather than study information.
    Difference
    0.4%
    Check dated 2026-02-11T02:05:56.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:41:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle, new navigation and document links (FDA Safety Alerts and Recalls, BMS Clinical Trial Information, Patient Recruiting), and attached PDFs; removed No FEAR Act data from the footer. No core study data or outcomes were changed.
    Difference
    53%
    Check dated 2026-01-27T23:23:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:32:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new consolidated Locations section was added, listing multiple region-specific groups (e.g., Alabama, California, Montana, New York, Pennsylvania, Ontario, Aichi-ken, Osaka, Tokyo, Eastern Cape, Gauteng, Western Cape). The previous individual location groups and the older revision label were removed.
    Difference
    1%
    Check dated 2025-12-23T10:19:03.000Z thumbnail image

Stay in the know with updates to Nivolumab Safety in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Safety in Lung Cancer Clinical Trial page.